News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Zealand's Protemix Corporation Limited Recruits US-based CEO


10/19/2005 5:12:40 PM

Biotech entrepreneur Garth Cooper has stepped sideways from his role as CEO of New Zealand biotech Protemix, appointing US-based former Eli Lilly executive Larry Ellingson to guide the company through pending Phase III trials of its drug for diabetic heart disease Laszarin.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES